News
Telomir-1 shows promising results in restoring vision and retinal structure in age-related macular degeneration, marking a ...
12h
Zacks Investment Research on MSNTBPH to Sell Remaining Trelegy Royalty Interest to GSK, Stock RisesTheravance Biopharma TBPH announced that it has entered into an agreement to sell its remaining royalty interest in net sales ...
16hon MSN
People who follow a MIND diet, even if started later in life, were significantly less likely to develop Alzheimer's disease ...
It would help the trials—and patients—if more people were tested for Alzheimer’s earlier on, so that they could be enrolled ...
In this video, Jay Chhablani, MD, discusses preliminary data from the ArMaDa study of OCU410 gene therapy for geographic atrophy presented at the ARVO meeting.
The asthma medication theophylline is a suitable drug for treating the rare neurological disorder ADCY5-related dyskinesia, ...
Amylyx Pharmaceuticals ( NASDAQ: AMLX) said on Tuesday that the U.S. FDA has granted fast track status to its antisense RNA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results